<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33634036</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Repurposing the Antiemetic Metoclopramide as an Antiviral Against Dengue Virus Infection in Neuronal Cells.</ArticleTitle><Pagination><StartPage>606743</StartPage><MedlinePgn>606743</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">606743</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2020.606743</ELocationID><Abstract><AbstractText>Dengue virus (DENV) is transmitted by Aedes mosquitoes to humans and is a threat worldwide. No effective new drugs have been used for anti-dengue treatment, and repurposing drugs is an alternative approach to treat this condition. Dopamine 2 receptor (D2R) is a host receptor positively associated with DENV infection. Metoclopramide (MCP), a D2R antagonist clinically used to control vomiting and nausea in patients with DENV infection, was putatively examined for inhibition of DENV infection by targeting D2R. In the mouse neural cell line Neuro-2a with D2R expression, a plaque assay demonstrated the antiviral efficacy of MCP treatment. However, in the cell line BHK-21, which did not express D2R, MCP treatment caused no further inhibition of DENV infection. Either MCP treatment or exogenous administration of a neutralizing D2R antibody blocked DENV binding. Treatment with MCP also reduced DENV dsRNA replication and DENV-induced neuronal cell cytotoxicity <i>in vitro</i>. An <i>in vivo</i> study demonstrated the antiviral effect of MCP against DENV-induced CNS neuropathy and mortality. These results showed that repurposing the D2R-targeting antiemetic MCP is a potential therapeutic strategy against DENV infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Shen, Hanh, Nguyen, Jhan, Ho and Lin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Ting-Jing</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanh</LastName><ForeName>Vu Thi</ForeName><Initials>VT</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Hematology and Blood Transfusion, Bach Mai Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Thai Quoc</ForeName><Initials>TQ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Tropical Diseases, Bach Mai Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jhan</LastName><ForeName>Ming-Kai</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Min-Ru</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chiou-Feng</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Diseases and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000932">Antiemetics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>L4YEB44I46</RegistryNumber><NameOfSubstance UI="D008787">Metoclopramide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000932" MajorTopicYN="Y">Antiemetics</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="Y">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="Y">Dengue Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008787" MajorTopicYN="N">Metoclopramide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiemetics</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">dopamine receptor</Keyword><Keyword MajorTopicYN="N">metoclopramide</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33634036</ArticleId><ArticleId IdType="pmc">PMC7902071</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2020.606743</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acosta E. G., Castilla V., Damonte E. B. (2008). Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis. J. Gen. Virol. 89 (Pt 2), 474&#x2013;484. &#xa0;10.1099/vir.0.83357-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83357-0</ArticleId><ArticleId IdType="pubmed">18198378</ArticleId></ArticleIdList></Reference><Reference><Citation>Aravapalli S., Lai H., Teramoto T., Alliston K. R., Lushington G. H., Ferguson E. L., et al. (2012). Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold. Bioorg. Med. Chem. 20 (13), 4140&#x2013;4148. &#xa0;10.1016/j.bmc.2012.04.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2012.04.055</ArticleId><ArticleId IdType="pmc">PMC3563422</ArticleId><ArticleId IdType="pubmed">22632792</ArticleId></ArticleIdList></Reference><Reference><Citation>Athavale A., Athavale T., Roberts D. M. (2020). Antiemetic drugs: what to prescribe and when. Aust. Prescr. 43 (2), 49&#x2013;56. &#xa0;10.18773/austprescr.2020.011</Citation><ArticleIdList><ArticleId IdType="doi">10.18773/austprescr.2020.011</ArticleId><ArticleId IdType="pmc">PMC7186277</ArticleId><ArticleId IdType="pubmed">32346211</ArticleId></ArticleIdList></Reference><Reference><Citation>Botta L., Rivara M., Zuliani V., Radi M. (2018). Drug repurposing approaches to fight Dengue virus infection and related diseases. Front. Biosci. Landmark 23, 997&#x2013;1019. 10.2741/4630</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/4630</ArticleId><ArticleId IdType="pubmed">28930586</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderon-Pelaez M. A., Velandia-Romero M. L., Bastidas-Legarda L. Y., Beltran E. O., Camacho-Ortega S. J., Castellanos J. E. (2019). Dengue Virus Infection of Blood-Brain Barrier Cells: Consequences of Severe Disease. Front. Microbiol. 10, 1435. &#xa0;10.3389/fmicb.2019.01435</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01435</ArticleId><ArticleId IdType="pmc">PMC6606788</ArticleId><ArticleId IdType="pubmed">31293558</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Oliveira C., Freire J. M., Concei&#xe7;&#xe3;o T. M., Higa L. M., Castanho M. A. R. B., Da Poian A. T. (2015). Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol. Rev. 39 (2), 155&#x2013;170. &#xa0;10.1093/femsre/fuu004</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuu004</ArticleId><ArticleId IdType="pubmed">25725010</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Guardia C., Lleonart R. (2014). Progress in the identification of dengue virus entry/fusion inhibitors. BioMed. Res. Int. 2014, 825039. 10.1155/2014/825039</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/825039</ArticleId><ArticleId IdType="pmc">PMC4135166</ArticleId><ArticleId IdType="pubmed">25157370</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miranda A. S., Rodrigues D. H., Amaral D. C., de Lima Campos R. D., Cisalpino D., Vilela M. C., et al. (2012). Dengue-3 encephalitis promotes anxiety-like behavior in mice. Behav. Brain Res. 230 (1), 237&#x2013;242. &#xa0;10.1016/j.bbr.2012.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2012.02.020</ArticleId><ArticleId IdType="pubmed">22366269</ArticleId></ArticleIdList></Reference><Reference><Citation>Despres P., Frenkiel M. P., Ceccaldi P. E., Duarte Dos Santos C., Deubel V. (1998). Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J. Virol. 72 (1), 823&#x2013;829. 10.1128/JVI.72.1.823-829.1998</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.1.823-829.1998</ArticleId><ArticleId IdType="pmc">PMC109443</ArticleId><ArticleId IdType="pubmed">9420294</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M. S., Harris E. (2001). Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology 289 (2), 297&#x2013;311. &#xa0;10.1006/viro.2001.1114</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1114</ArticleId><ArticleId IdType="pubmed">11689052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson N. M. (2018). Challenges and opportunities in controlling mosquito-borne infections. Nature 559 (7715), 490&#x2013;497. &#xa0;10.1038/s41586-018-0318-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0318-5</ArticleId><ArticleId IdType="pubmed">30046071</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaskill P. J., Calderon T. M., Luers A. J., Eugenin E. A., Javitch J. A., Berman J. W. (2009). Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am. J. Pathol. 175 (3), 1148&#x2013;1159. 10.2353/ajpath.2009.081067</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.081067</ArticleId><ArticleId IdType="pmc">PMC2731133</ArticleId><ArticleId IdType="pubmed">19661443</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaskill P. J., Yano H. H., Kalpana G. V., Javitch J. A., Berman J. W. (2014). Dopamine receptor activation increases HIV entry into primary human macrophages. PloS One 9 (9), e108232. 10.1371/journal.pone.0108232</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0108232</ArticleId><ArticleId IdType="pmc">PMC4182469</ArticleId><ArticleId IdType="pubmed">25268786</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M. G., Halstead S. B., Artsob H., Buchy P., Farrar J., Gubler D. J., et al. (2010). Dengue: a continuing global threat. Nat. Rev. Microbiol. 8 (12supp), S7. 10.1038/nrmicro2460</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M. G., Gubler D. J., Izquierdo A., Martinez E., Halstead S. B. (2016). Dengue infection. Nat. Rev. Dis. Primers 2, 16055. &#xa0;10.1038/nrdp.2016.55</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.55</ArticleId><ArticleId IdType="pubmed">27534439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadinegoro S. R. S. (2012). The revised WHO dengue case classification: does the system need to be modified? Paediatr. Int. Child Health 32 (sup1), 33&#x2013;38. 10.1179/2046904712Z.00000000052</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/2046904712Z.00000000052</ArticleId><ArticleId IdType="pmc">PMC3381438</ArticleId><ArticleId IdType="pubmed">22668448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M.-R., Tsai T.-T., Chen C.-L., Jhan M.-K., Tsai C.-C., Lee Y.-C., et al. (2017). Blockade of dengue virus infection and viral cytotoxicity in neuronal cells in vitro and in vivo by targeting endocytic pathways. Sci. Rep. 7 (1), 6910. 10.1038/s41598-017-07023-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07023-z</ArticleId><ArticleId IdType="pmc">PMC5537343</ArticleId><ArticleId IdType="pubmed">28761128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito K., Haga T., Lameh J., Sad&#xe9;e W. (1999). Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur. J. Biochem. 260 (1), 112&#x2013;119. 10.1046/j.1432-1327.1999.00125.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1327.1999.00125.x</ArticleId><ArticleId IdType="pubmed">10091590</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan J. T., Chen B. H., Ma S. H., Liu C., II, Tsai H. P., Wu H. C., et al. (2000). Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved. J. Virol. 74 (18), 8680&#x2013;8691. &#xa0;10.1128/jvi.74.18.8680-8691.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.18.8680-8691.2000</ArticleId><ArticleId IdType="pmc">PMC116379</ArticleId><ArticleId IdType="pubmed">10954569</ArticleId></ArticleIdList></Reference><Reference><Citation>Joubert J., Foxen E. B., Malan S. F. (2018). Microwave Optimized Synthesis of N-(adamantan-1-yl)-4-[(adamantan-1-yl)-sulfamoyl]benzamide and Its Derivatives for Anti-Dengue Virus Activity. Molecules 23 (7), 1678. &#xa0;10.3390/molecules23071678</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23071678</ArticleId><ArticleId IdType="pmc">PMC6099921</ArticleId><ArticleId IdType="pubmed">29996497</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong A. S.-Y., Wong K. T., Leong T. Y.-M., Tan P. H., Wannakrairot P. (2007). The pathology of dengue hemorrhagic fever. Semin. Diagn. Pathol. 24 (4), 227&#x2013;236. 10.1053/j.semdp.2007.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semdp.2007.07.002</ArticleId><ArticleId IdType="pubmed">18085063</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z., Wu S., Li Y., He L., Wu M., Jiang L., et al. (2011). Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-beta in cultured hepatoma cells. PloS One 6 (8), e23346. &#xa0;10.1371/journal.pone.0023346</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023346</ArticleId><ArticleId IdType="pmc">PMC3150425</ArticleId><ArticleId IdType="pubmed">21829730</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A. R., de Matos G. F., Janeri R. D., Machado P. S., Schvartsman C., Dos Santos O. F. (2011). Managing patients with dengue fever during an epidemic: the importance of a hydration tent and of a multidisciplinary approach. BMC Res. Notes 4, 335. &#xa0;10.1186/1756-0500-4-335</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-4-335</ArticleId><ArticleId IdType="pmc">PMC3180466</ArticleId><ArticleId IdType="pubmed">21902823</ArticleId></ArticleIdList></Reference><Reference><Citation>Milligan G. N., Sarathy V. V., Infante E., Li L., Campbell G. A., Beatty P. R., et al. (2015). A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice. PloS One 10 (5), e0125476. &#xa0;10.1371/journal.pone.0125476</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125476</ArticleId><ArticleId IdType="pmc">PMC4418603</ArticleId><ArticleId IdType="pubmed">25938762</ArticleId></ArticleIdList></Reference><Reference><Citation>Milligan G. N., Sarathy V. V., White M. M., Greenberg M. B., Campbell G. A., Pyles R. B., et al. (2017). A lethal model of disseminated dengue virus type 1 infection in AG129 mice. J. Gen. Virol. 98 (10), 2507&#x2013;2519. &#xa0;10.1099/jgv.0.000923</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000923</ArticleId><ArticleId IdType="pmc">PMC5845568</ArticleId><ArticleId IdType="pubmed">28949904</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen T. J., Jhan M. K., Kao J. C., Ho M. R., Tsai T. T., Tseng P. C., et al. (2019). A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease. J. Vis. Exp. 146, e59132. &#xa0;10.3791/59132</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/59132</ArticleId><ArticleId IdType="pubmed">31081826</ArticleId></ArticleIdList></Reference><Reference><Citation>Shresta S., Kyle J. L., Snider H. M., Basavapatna M., Beatty P. R., Harris E. (2004). Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J. Virol. 78 (6), 2701&#x2013;2710. &#xa0;10.1128/jvi.78.6.2701-2710.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.78.6.2701-2710.2004</ArticleId><ArticleId IdType="pmc">PMC353772</ArticleId><ArticleId IdType="pubmed">14990690</ArticleId></ArticleIdList></Reference><Reference><Citation>Simanjuntak Y., Liang J.-J., Lee Y.-L., Lin Y.-L. (2014). Repurposing of prochlorperazine for use against dengue virus infection. J. Infect. Dis. 211 (3), 394&#x2013;404. 10.1093/infdis/jiu377</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu377</ArticleId><ArticleId IdType="pubmed">25028694</ArticleId></ArticleIdList></Reference><Reference><Citation>Simanjuntak Y., Liang J. J., Lee Y. L., Lin Y. L. (2017). Japanese Encephalitis Virus Exploits Dopamine D2 Receptor-phospholipase C to Target Dopaminergic Human Neuronal Cells. Front. Microbiol. 8, 651. &#xa0;10.3389/fmicb.2017.00651</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.00651</ArticleId><ArticleId IdType="pmc">PMC5387065</ArticleId><ArticleId IdType="pubmed">28443089</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J. L., Stein D. A., Shum D., Fischer M. A., Radu C., Bhinder B., et al. (2014). Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling. J. Virol. 88 (10), 5533&#x2013;5542. 10.1128/JVI.00365-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00365-14</ArticleId><ArticleId IdType="pmc">PMC4019099</ArticleId><ArticleId IdType="pubmed">24599995</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Dung N. M., Vaughn D. W., Kneen R., Raengsakulrach B., Loan H. T., et al. (2000). Neurological manifestations of dengue infection. Lancet 355 (9209), 1053&#x2013;1059. 10.1016/S0140-6736(00)02036-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02036-5</ArticleId><ArticleId IdType="pubmed">10744091</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprokholt J. K., Kaptein T. M., van Hamme J. L., Overmars R. J., Gringhuis S., II, Geijtenbeek T. B. H. (2017). RIG-I-like Receptor Triggering by Dengue Virus Drives Dendritic Cell Immune Activation and TH1 Differentiation. J. Immunol. 198 (12), 4764&#x2013;4771. &#xa0;10.4049/jimmunol.1602121</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1602121</ArticleId><ArticleId IdType="pubmed">28507028</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai T. T., Chen C. L., Lin Y. S., Chang C. P., Tsai C. C., Cheng Y. L., et al. (2016). Microglia retard dengue virus-induced acute viral encephalitis. Sci. Rep. 6, 27670. &#xa0;10.1038/srep27670</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27670</ArticleId><ArticleId IdType="pmc">PMC4899773</ArticleId><ArticleId IdType="pubmed">27279150</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuiskunen B&#xe4;ck A., Lundkvist &#xc5;. (2013). Dengue viruses&#x2013;an overview. Infect. Ecol. Epidemiol. 3 (1), 19839. 10.3402/iee.v3i0.19839</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/iee.v3i0.19839</ArticleId><ArticleId IdType="pmc">PMC3759171</ArticleId><ArticleId IdType="pubmed">24003364</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Schaar H. M., Rust M. J., Chen C., van der Ende-Metselaar H., Wilschut J., Zhuang X., et al. (2008). Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PloS Pathog. 4 (12), e1000244. 10.1371/journal.ppat.1000244</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000244</ArticleId><ArticleId IdType="pmc">PMC2592694</ArticleId><ArticleId IdType="pubmed">19096510</ArticleId></ArticleIdList></Reference><Reference><Citation>Velandia-Romero M. L., Acosta-Losada O., Castellanos J. E. (2012). In vivo infection by a neuroinvasive neurovirulent dengue virus. J. Neurovirol. 18 (5), 374&#x2013;387. &#xa0;10.1007/s13365-012-0117-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-012-0117-y</ArticleId><ArticleId IdType="pubmed">22825914</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma R., Sahu R., Holla V. (2014). Neurological manifestations of dengue infection: a review. J. Neurol. Sci. 346 (1&#x2013;2), 26&#x2013;34. 10.1016/j.jns.2014.08.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.08.044</ArticleId><ArticleId IdType="pubmed">25220113</ArticleId></ArticleIdList></Reference><Reference><Citation>Welliver M. (2014). Dopamine antagonists for nausea and vomiting: special considerations. Gastroenterol. Nurs. 37 (5), 361&#x2013;364. 10.1097/SGA.0000000000000068</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SGA.0000000000000068</ArticleId><ArticleId IdType="pubmed">25271829</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsch S., Miller S., Romero-Brey I., Merz A., Bleck C. K., Walther P., et al. (2009). Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5 (4), 365&#x2013;375. 10.1016/j.chom.2009.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.03.007</ArticleId><ArticleId IdType="pmc">PMC7103389</ArticleId><ArticleId IdType="pubmed">19380115</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu I.-M., Zhang W., Holdaway H. A., Li L., Kostyuchenko V. A., Chipman P. R., et al. (2008). Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319 (5871), 1834&#x2013;1837. 10.1126/science.1153264</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1153264</ArticleId><ArticleId IdType="pubmed">18369148</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaitseva E., Yang S.-T., Melikov K., Pourmal S., Chernomordik L. V. (2010). Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PloS Pathog. 6 (10), e1001131. 10.1371/journal.ppat.1001131</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001131</ArticleId><ArticleId IdType="pmc">PMC2951369</ArticleId><ArticleId IdType="pubmed">20949067</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>